248 related articles for article (PubMed ID: 22407378)
1. Dopamine, the kidney, and hypertension.
Harris RC; Zhang MZ
Curr Hypertens Rep; 2012 Apr; 14(2):138-43. PubMed ID: 22407378
[TBL] [Abstract][Full Text] [Related]
2. Abnormalities in renal dopamine signaling and hypertension: the role of GRK4.
Harris RC
Curr Opin Nephrol Hypertens; 2012 Jan; 21(1):61-5. PubMed ID: 22123211
[TBL] [Abstract][Full Text] [Related]
3. Dopamine and G protein-coupled receptor kinase 4 in the kidney: role in blood pressure regulation.
Jose PA; Soares-da-Silva P; Eisner GM; Felder RA
Biochim Biophys Acta; 2010 Dec; 1802(12):1259-67. PubMed ID: 20153824
[TBL] [Abstract][Full Text] [Related]
4. Antihypertensive mechanisms of intra-renal dopamine.
Zhang MZ; Harris RC
Curr Opin Nephrol Hypertens; 2015 Mar; 24(2):117-22. PubMed ID: 25594544
[TBL] [Abstract][Full Text] [Related]
5. Renal Dopamine Receptors and Oxidative Stress: Role in Hypertension.
Yang J; Villar VAM; Jose PA; Zeng C
Antioxid Redox Signal; 2021 Mar; 34(9):716-735. PubMed ID: 32349533
[No Abstract] [Full Text] [Related]
6. Mechanisms of disease: the role of GRK4 in the etiology of essential hypertension and salt sensitivity.
Felder RA; Jose PA
Nat Clin Pract Nephrol; 2006 Nov; 2(11):637-50. PubMed ID: 17066056
[TBL] [Abstract][Full Text] [Related]
7. Human GRK4γ142V Variant Promotes Angiotensin II Type I Receptor-Mediated Hypertension via Renal Histone Deacetylase Type 1 Inhibition.
Wang Z; Zeng C; Villar VA; Chen SY; Konkalmatt P; Wang X; Asico LD; Jones JE; Yang Y; Sanada H; Felder RA; Eisner GM; Weir MR; Armando I; Jose PA
Hypertension; 2016 Feb; 67(2):325-34. PubMed ID: 26667412
[TBL] [Abstract][Full Text] [Related]
8. The importance of G protein-coupled receptor kinase 4 (GRK4) in pathogenesis of salt sensitivity, salt sensitive hypertension and response to antihypertensive treatment.
Rayner B; Ramesar R
Int J Mol Sci; 2015 Mar; 16(3):5741-9. PubMed ID: 25775155
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive insights in GRK4 and hypertension: From mechanisms to potential therapeutics.
Yang J; Hall JE; Jose PA; Chen K; Zeng C
Pharmacol Ther; 2022 Nov; 239():108194. PubMed ID: 35487286
[TBL] [Abstract][Full Text] [Related]
10. A novel role for c-Myc in G protein-coupled receptor kinase 4 (GRK4) transcriptional regulation in human kidney proximal tubule cells.
Gildea JJ; Tran HT; Van Sciver RE; Bigler Wang D; Carlson JM; Felder RA
Hypertension; 2013 May; 61(5):1021-7. PubMed ID: 23509080
[TBL] [Abstract][Full Text] [Related]
11. Dopamine and the kidney: a role in hypertension?
Jose PA; Eisner GM; Felder RA
Curr Opin Nephrol Hypertens; 2003 Mar; 12(2):189-94. PubMed ID: 12589180
[TBL] [Abstract][Full Text] [Related]
12. Role of GRK4 in the regulation of arterial AT1 receptor in hypertension.
Chen K; Fu C; Chen C; Liu L; Ren H; Han Y; Yang J; He D; Zhou L; Yang Z; Zhang L; Jose PA; Zeng C
Hypertension; 2014 Feb; 63(2):289-96. PubMed ID: 24218433
[TBL] [Abstract][Full Text] [Related]
13. Effects of decreased renal cortical expression of G protein-coupled receptor kinase 4 and angiotensin type 1 receptors in rats.
Yatabe J; Sanada H; Midorikawa S; Hashimoto S; Watanabe T; Andrews PM; Armando I; Wang X; Felder RA; Jose PA
Hypertens Res; 2008 Jul; 31(7):1455-64. PubMed ID: 18957817
[TBL] [Abstract][Full Text] [Related]
14. Dopamine Receptor D
Zeng C; Armando I; Yang J; Jose PA
Yale J Biol Med; 2023 Mar; 96(1):95-105. PubMed ID: 37009199
[TBL] [Abstract][Full Text] [Related]
15. Single-nucleotide polymorphisms for diagnosis of salt-sensitive hypertension.
Sanada H; Yatabe J; Midorikawa S; Hashimoto S; Watanabe T; Moore JH; Ritchie MD; Williams SM; Pezzullo JC; Sasaki M; Eisner GM; Jose PA; Felder RA
Clin Chem; 2006 Mar; 52(3):352-60. PubMed ID: 16439609
[TBL] [Abstract][Full Text] [Related]
16. Interactions between the intrarenal dopaminergic and the renin-angiotensin systems in the control of systemic arterial pressure.
Vaz de Castro PAS; Jose PA; Simões E Silva AC
Clin Sci (Lond); 2022 Aug; 136(16):1205-1227. PubMed ID: 35979889
[TBL] [Abstract][Full Text] [Related]
17. Functional genomics of the dopaminergic system in hypertension.
Zeng C; Sanada H; Watanabe H; Eisner GM; Felder RA; Jose PA
Physiol Genomics; 2004 Nov; 19(3):233-46. PubMed ID: 15548830
[TBL] [Abstract][Full Text] [Related]
18. ELABELA antagonizes intrarenal renin-angiotensin system to lower blood pressure and protects against renal injury.
Xu C; Wang F; Chen Y; Xie S; Sng D; Reversade B; Yang T
Am J Physiol Renal Physiol; 2020 May; 318(5):F1122-F1135. PubMed ID: 32174138
[TBL] [Abstract][Full Text] [Related]
19. Amelioration of genetic hypertension by suppression of renal G protein-coupled receptor kinase type 4 expression.
Sanada H; Yatabe J; Midorikawa S; Katoh T; Hashimoto S; Watanabe T; Xu J; Luo Y; Wang X; Zeng C; Armando I; Felder RA; Jose PA
Hypertension; 2006 Jun; 47(6):1131-9. PubMed ID: 16636192
[TBL] [Abstract][Full Text] [Related]
20. Role of GRK4 in the regulation of the renal ETB receptor in hypertension.
Yang Y; Li M; Zou X; Chen C; Zheng S; Fu C; Chen K; Jose PA; Lan C; Liu Y
FASEB J; 2020 Sep; 34(9):11594-11604. PubMed ID: 32687659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
